ITCMDBv1
Clinical TrialID 8556

Pilot Evaluation of CVT-E002 in Pediatric Upper Respiratory Tract Infection.

NCT00255307

Upper Respiratory Infection

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
8556
Evidence Id
8556
Core Evidence Id
8556
Source Clinical Trial Id
8556
Herb2 Clinical Trial Id
HBCT008556
Nct Id
NCT00255307
Title
Pilot Evaluation of CVT-E002 in Pediatric Upper Respiratory Tract Infection.
Status
Completed
Phase
Phase 2
Study Result
No
Study Condition
Upper Respiratory Infection
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
Intervention
DRUG: CVT-E002 ginseng extract
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Double
Intervention Purpose
Treatment
Gender
All
Age
Child
Enrollment
75
Outcome Measure
To establish preliminary estimate of treatment effect of two doses of American ginseng extract, CVT-E002, in reducing severity and duration of URTI in children
Sponsor Collaborator
CV Technologies|University of Alberta|Capital Health, Canada
Funded By
INDUSTRY
Location
Stollery Children's Hospital, Edmonton, Alberta, T6G 2R7, Canada|Misericordia Child Health Clinic, Edmonton, Alberta, Canada
Other Id
CVT-E002-2005-4
Start Date
2005-11-01 00:00:00
Primary Completion Date
Completion Date
2006-04-01 00:00:00
First Posted
2005-11-18 00:00:00
Results First Posted
Last Update Posted
2007-06-18 00:00:00
Study Document
Study Url
https://clinicaltrials.gov/study/NCT00255307
Title Cn
Title En
Pilot Evaluation of CVT-E002 in Pediatric Upper Respiratory Tract Infection.
Bilingual Status
semi_complete